Too Rare To Die

Brain Massage | Why Joshua Ismin Develops Next-Generation Psychedelics for Mental Illness at Psylo

Listen Later

Featuring Joshua Ismin, Co-Founder & CEO of Psylo - a drug-development company that’s focused on next-generation psychedelics. They R&D new psychedelic drugs to treat mental illness in ways traditional medicine has failed.


This episode is about psychedelics & mental illness. Can we handle it?

Join our conversations about:

  • The stigma of psychedelics
  • The science of psychedelics - is the trip real?
  • The side effects, risks, precautions & tradeoffs in trippy drugs
  • Doc's first-person experience of ketamine-assisted therapy
  • The "afterglow" effect
  • Legalisation & decriminalisation of drugs - should it be free for all?

    • Why are people now heavily backing psychedelics? Do these drugs actually work? Should you take them seriously? Which drugs are getting legalised this year? Hear the full conversation, and about Psylo's latest project - non-psychedelic psychedelics.


    Starring a guest co-host; Argentino Molinuevo (aka Tino, aka Handsome) - Business Development Team Lead at Athyna, with a questionable interest in psychedelics, LOL!

    Hosted by Bill Kerr & Walo Olapoju, produced by Matías Rosenberg & Celeste Bono and creative direction by Josefina Cordoba.

    This show was sponsored by Athyna. Hire, manage and retain world-class global talent at www.athyna.io/rare.

    Song lyrics:
    From outer space to inner peace,
    Science fiction on its knees,
    Everything is make believe,
    Let go of reality,
    Handing out the 'shrooms,
    who's...Joshua Ismin, Ismin

    ...more
    View all episodesView all episodes
    Download on the App Store
    Too Rare To DieBy Athyna